AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Automated ECG interpretation system gains FDA clearance ...
MOUNTAIN VIEW, Calif., Jan. 16, 2025 /PRNewswire/ -- AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the Centers for Medicare & ...
The Skeptical Cardiologist has been evaluating a demo version of AliveCor's new KardiaMobile 6L. I have been a huge advocate of Kardia's single-lead ECG and use it with great success in dozens of my ...
BELLEVUE, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis ...
For decades one of the holy grails of medical diagnostic devices has been the non-invasive glucose monitor. From wrist-watches to contact lenses, the alluring dream of a device to continually monitor ...
Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for healthcare settings to detect 35 cardiac determinations, including heart ...
Please provide your email address to receive an email when new articles are posted on . Vektor Medical announced the FDA has given 510(k) clearance for its novel ECG mapping system, designed to map ...
ANN ARBOR, Mich., Nov. 9, 2011 /PRNewswire/ — Everist Genomics, a rapidly growing personalized medicine company developing and commercializing innovative diagnostics and prognostics, today announced ...